Innoviva, Inc. (INVA) stock
INVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3040% below fair value
$19.03+0.06 (+0.32%)
Close on Nov 13, 2026Market cap $1.37BP/E 9.7Yield –
Innoviva statistics
99 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 24, 2027 (estimated, during market hours)
- Last ex-dividend date
- Sep 8, 2015
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.44
- 2.22
- P/OCF Ratio
- 7.49
- 12.99
Enterprise valuationIndustry
- EV / Sales
- 2.40
- 2.57
- EV / EBIT
- 6.18
- 19.31
- EV / FCF
- 5.77
- 22.27
Share statisticsIndustry
- Shares Change (YoY)
- -7.11%
- 10.8%
- Shares Change (QoQ)
- -1.52%
- 0.50%
- Float
- 68M
- 49M
- Shares Held by Insiders
- 5.38%
- 11.7%
- Shares Held by Institutions
- 104.1%
- 56.4%
Short sellingIndustry
- Short Interest
- 7M
- –
- Short Interest Change
- 3.16%
- -0.80%
- Short % of Float
- 11.0%
- 9.01%
- Short % of Shares Outstanding
- 10.4%
- 6.30%
- Days to Cover
- 12.88
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $25.14
- –
- 52-Week Low
- $18.66
- –
- 20-Day Moving Average
- $20.36
- –
- 50-Day Moving Average
- $20.70
- –
- 200-Day Moving Average
- $21.89
- –
- Average True Range (14)
- $0.65
- –
- Price Change (1 Week)
- -0.37%
- -1.15%
- Price Change (1 Month)
- -8.77%
- -4.87%
- Price Change (3 Months)
- -9.21%
- -21.0%
- Price Change (6 Months)
- -13.4%
- -20.6%
- Price Change (YTD)
- -4.80%
- -23.6%
- Price Change (1 Year)
- -14.6%
- -22.4%
- Price Change (3 Years)
- 37.0%
- -29.5%
- Price Change (5 Years)
- 7.15%
- -77.9%
- Price Change (10 Years)
- 70.4%
- -65.4%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 862,136
- –
- Average Volume (90 Days)
- 815,546
- –
- Relative Volume
- 0.69
- 0.70
- Relative Strength Index (14)
- 33.1
- 43.4
- Volatility (1 Year)
- 25.2%
- 80.1%
- Beta (5 Years)
- 0.23
- 1.07
MarginsIndustry
- Pretax Margin
- 51.1%
- -11.6%
- EBITDA Margin
- 38.8%
- -27.7%
- FCF Margin
- 41.6%
- -9.56%
Returns on capitalIndustry
- Return on Invested Capital (ROIC)
- 18.0%
- -32.9%
- Return on Capital Employed (ROCE)
- 11.4%
- -37.9%
Financial positionIndustry
- Current Ratio
- 15.44
- 3.30
- Quick Ratio
- 12.50
- 2.39
- Debt / Equity
- 0.23
- 0.49
- Debt / EBITDA
- 1.52
- 3.15
- Debt / FCF
- 1.42
- 4.65
- Net Debt / EBITDA
- -1.90
- 1.97
- Interest Coverage
- 8.64
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 12.8%
- 6.82%
- FCF Growth (YoY)
- -8.99%
- 6.85%
- Revenue Growth (3Y CAGR)
- 7.47%
- 2.25%
- Revenue Growth (5Y CAGR)
- 4.08%
- 6.41%
- EPS Growth (3Y CAGR)
- 11.7%
- 1.30%
- EPS Growth (5Y CAGR)
- 10.3%
- 3.78%
EfficiencyIndustry
- Asset Turnover
- 0.30
- 0.40
- Inventory Turnover
- 2.75
- 2.73
- Revenue Per Employee
- $2.76M
- $429.29K
- Employee Count
- 159
- 74
- WACC
- 7.44%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- $223.97M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $322.57M
- $17.76M
- Net Cash Per Share
- $4.46
- $0.80
- Equity (Book Value)
- $1.14B
- $53.89M
- Book Value Per Share
- $15.75
- $1.50
- Tangible Book Value
- $957.34M
- $27.13M
- Working Capital
- $722.22M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$955.00K
- -$1.00M
- FCF Per Share
- $2.53
- -$0.42
Dividends and yieldsIndustry
- FCF Yield
- 13.3%
- -9.44%
- Buyback Yield
- 5.69%
- -0.76%
- Shareholder Yield
- 5.69%
- 0.00%
Taxes and interestIndustry
- Interest Expense
- $19.69M
- $2.90M
- Income Tax
- $30.53M
- $73.00K
- Effective Tax Rate
- 13.6%
- 20.9%
Scores and fair valueIndustry
- Graham Number
- $26.42
- $19.34
- Graham Upside
- 38.8%
- -46.6%
- Altman Z-Score
- 3.55
- 0.23
- Lynch Fair Value
- $20.32
- –
- Lynch Upside
- 6.78%
- -28.9%
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | INVA | S&P 500 | Difference | INVA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -8.2% | -3.0% | −5.2 pts | ||
| 3 months | -8.3% | -2.8% | −5.5 pts | ||
| Year to date | -4.8% | +11.5% | −16.3 pts | ||
| 1 year | -14.3% | +13.5% | −27.7 pts | ||
| 3 years | +39.5% | +77.7% | −38.2 pts | +11.7% | +21.1% |
| 5 years | +7.2% | +72.6% | −65.5 pts | +1.4% | +11.5% |
| 10 years | +73.9% | +308.2% | −234.2 pts | +5.7% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
7M INVA shares were sold short on Oct 30, 2026, up 3.2% from the previous report, or 10.96% of the shares available to trade. At recent volumes it would take 12.9 days to buy them back. Over the last 20 sessions, 51.3% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 7,495,210 | +3.2% | 582,044 | 12.9 |
| Oct 15, 2026 | 7,265,728 | +6.1% | 701,241 | 10.4 |
| Sep 30, 2026 | 6,845,485 | -4.2% | 1,209,089 | 5.7 |
| Sep 15, 2026 | 7,144,265 | +2.9% | 767,768 | 9.3 |
| Aug 31, 2026 | 6,940,337 | +1.1% | 588,655 | 11.8 |
| Aug 14, 2026 | 6,864,277 | -0.4% | 748,239 | 9.2 |
| Jul 31, 2026 | 6,892,081 | -1.8% | 597,565 | 11.5 |
| Jul 15, 2026 | 7,015,897 | +5.6% | 930,151 | 7.5 |
| Jun 30, 2026 | 6,645,977 | +0.7% | 980,223 | 6.8 |
| Jun 15, 2026 | 6,598,321 | +12.6% | 876,569 | 7.5 |
| May 29, 2026 | 5,859,814 | -8.4% | 949,527 | 6.2 |
| May 15, 2026 | 6,395,967 | +1.8% | 669,733 | 9.6 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?